Key facts
- This page summarizes Stephen Ray Mitchell's Form 4 filing for Vanda Pharmaceuticals Inc. (VNDA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 May 2026, 16:49.
Stephen Ray Mitchell - 18 May 2026 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)
- Reporting relationship
- Director
- Issuer ticker
- VNDA
- Reported as of
- 18 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 May 2026, 16:49:38 UTC
- Prior SEC filing
- 16 Jun 2025
- Next SEC filing
- 08 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen Ray Mitchell
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stephen Ray Mitchell filed Form 4 for Vanda Pharmaceuticals Inc. (VNDA) on 20 May 2026.
Change
- Previous filing in this sequence was filed on 16 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001802653
Primary reporting owner
Mitchell Stephen Ray
- Relationship
- Director
- Address
- C/O VANDA PHARMACEUTICALS INC., 2200 PENNSYLVANIA AVENUE, SUITE 300E, WASHINGTON
- Signature
- /s/ Stephen Ray Mitchell
- Signature date
- 19 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VNDA
transaction
Common Stock
Gift
- Transaction value
- Shares
- -25,836
- Change %
- -27%
- Price
- $0.000000*
- Shares after
- 71,246
- Date
- 18 May 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents a gift to a charitable organization.